Maccura Biotechnology Co Ltd (300463) — Net Asset Quality Index
Maccura Biotechnology Co Ltd (300463) has a Net Asset Quality Index of 79.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥7.99 Billion minus total liabilities of CN¥1.68 Billion yields net assets of CN¥6.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300463 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Maccura Biotechnology Co Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how Maccura Biotechnology Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 79.0%, representing net assets of CN¥6.31 Billion against total assets of CN¥7.99 Billion CNY. Explore Maccura Biotechnology Co Ltd (300463) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Maccura Biotechnology Co Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Maccura Biotechnology Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Maccura Biotechnology Co Ltd stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.9% | CN¥6.31 Billion | CN¥7.99 Billion | CN¥1.69 Billion | ▼ -1.7 pp |
| 2024 | 80.5% | CN¥6.42 Billion | CN¥7.98 Billion | CN¥1.55 Billion | ▼ -0.9 pp |
| 2023 | 81.4% | CN¥6.61 Billion | CN¥8.12 Billion | CN¥1.51 Billion | ▲ +1.4 pp |
| 2022 | 80.0% | CN¥6.53 Billion | CN¥8.16 Billion | CN¥1.63 Billion | ▲ +10.8 pp |
| 2021 | 69.2% | CN¥4.54 Billion | CN¥6.57 Billion | CN¥2.03 Billion | ▲ +6.2 pp |
| 2020 | 62.9% | CN¥4.01 Billion | CN¥6.36 Billion | CN¥2.36 Billion | ▲ +2.4 pp |
| 2019 | 60.5% | CN¥3.33 Billion | CN¥5.50 Billion | CN¥2.17 Billion | ▼ -2.3 pp |
| 2018 | 62.9% | CN¥2.86 Billion | CN¥4.56 Billion | CN¥1.69 Billion | ▼ -10.0 pp |
| 2017 | 72.9% | CN¥2.61 Billion | CN¥3.58 Billion | CN¥970.12 Million | ▼ -11.7 pp |
| 2016 | 84.6% | CN¥2.28 Billion | CN¥2.70 Billion | CN¥415.01 Million | ▲ +0.3 pp |
| 2015 | 84.3% | CN¥2.00 Billion | CN¥2.37 Billion | CN¥371.71 Million | ▲ +19.2 pp |
| 2014 | 65.1% | CN¥792.05 Million | CN¥1.22 Billion | CN¥424.27 Million | ▼ -7.1 pp |
| 2013 | 72.2% | CN¥604.48 Million | CN¥837.02 Million | CN¥232.53 Million | ▲ +1.9 pp |
| 2012 | 70.4% | CN¥442.98 Million | CN¥629.52 Million | CN¥186.54 Million | ▲ +8.7 pp |
| 2011 | 61.7% | CN¥311.77 Million | CN¥505.16 Million | CN¥193.39 Million | — |